Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Yidu Tech Announces Annual Results for Fiscal Year 2021 2021-06-29 14:18
BioVaxys Announces Non-Brokered Private Placement 2021-06-29 10:46
The Pure Zone® Protection Film Is 97% Active Against SARS-CoV-2*, The Strain Causing Covid-19* 2021-06-29 08:37
RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study 2021-06-28 19:00
New Late-Breaking Data at The American Diabetes Association Show GlycoMark® May Be an Effective Test for COVID-19 Severity 2021-06-28 19:00
The Third Asia Pacific Psychiatry Symposium Takes Place 2021-06-28 15:51
Active8me Announces New Health Tech Partnership 2021-06-28 12:00
BIO Asia-Taiwan 2021 to Go Ahead in 'All Online' Format 2021-06-28 07:30
China's Public Health System Primed for Digital Innovation Online/Offline Service Delivery 'Huge Growth Opportunity', says Ping An Co-CEO 2021-06-25 21:19
I-Mab Announces China NMPA Approval for Phase 1b Trial of Felzartamab in Systemic Lupus Erythematosus 2021-06-25 20:00
Happiness Biotech Announces $2.16 Million Registered Direct Offering To Strategic Investors 2021-06-25 20:00
Vazyme Brings COVID-19 Testing Solutions at Medlab 2021 2021-06-25 15:31
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture 2021-06-25 12:57
GenScript receives "Best Contract Development and Manufacturing Organization Award" in the Korea Bioprocessing Excellence Awards 2021 2021-06-25 10:30
Moving ahead: Copan announces a major rebranding and launches a new website 2021-06-25 08:25
GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems 2021-06-24 22:33
People-Centric 'Korean Digital New Deal' 2021-06-24 20:30
Long-Term COVID-19 Fears Drive Major Shift in Household Savings in Asia 2021-06-24 15:14
BLS International partners with Knowledge Catalyst to issue Digital Health Certificates 2021-06-24 08:00
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial 2021-06-23 21:21
1 90 91 92 93 94 226